
    
      A total of 525 eligible subjects with early untreated Parkinson's disease (PD), will be
      randomized to 4 treatment groups. Each subject will participate in the study for
      approximately 18 weeks including a 30 day screening period, 12 week treatment period, and 2
      weeks follow-up period. Subjects will be requested to take one capsule and 1-3 tablets of
      study drug by mouth with a glass of water every day for 13 weeks. The study requires seven
      visits to the clinic one every 2-4 weeks.
    
  